161
Views
17
CrossRef citations to date
0
Altmetric
Articles

Correlation between DAS-28 and neopterin as a biochemical marker of immune system activation in early rheumatoid arthritis

, , , , , & show all
Pages 44-49 | Received 02 Feb 2012, Accepted 01 Aug 2012, Published online: 11 Oct 2012

References

  • Firestein G.. Evolving concepts of rheumatoid arthritis. Nature. 2003; 423:356–361.
  • Murr C., Widner B., Wirleitner B., Fuchs D.. Neopterin as a marker for immune system activation. Curr. Drug Metabol.. 2002; 3:175–187.
  • Schroecksnadel K., Kaser S., Ledochowski M., . Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. J. Rheumatol.. 2003; 30:1935–1939.
  • Berdowska A., Zwirska-Korczala K.. Neopterin measurement in clinical diagnosis. J. Clin. Pharm. Therap.. 2001; 26:319–329.
  • Schroecksnadel K., Murr C., Winkler C., . Neopterin to monitor clinical pathologies involving IFN-γ production. Pteridines. 2004; 15:75–90.
  • Honlinger M., Fuchs D., Hausen A., . Serum neopterin determination for the additional safeguarding of blood transfusions. Our experiences with 76,587 blood donors. Dtsch. Med. Wochenschr.. 1989; 114:172–176.
  • Micha Nübling C., Chudy M., Volkers P., Löwer J.. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection. Transfusion. 2006; 46:1886–1891.
  • Hoffmann G., Schobersberger W.. Neopterin: A mediator of the cellular immune system. Pteridines. 2004; 15:107–112.
  • Westermann J., Thiemann F., Gerstner L., . Evaluation of a new simple and rapid enzyme-linked immunosorbent assay kit for neopterin determination. Clin. Chem. Lab. Med.. 2000; 38:345–353.
  • Visser H.. Early diagnosis of rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol.. 2005; 19:55–72.
  • Prevoo M. L., Van Riel P. L. C. M., Van't Hof M. A., . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum.. 1995; 38:44–48.
  • Aziz N., Nishanian P., Fahey J. L.. Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: Quality controls procedures. Clin. Diagn. Lab. Immunol.. 1998; 5:755–761.
  • Mallya R. K., de Beer F. C., Berry H., . Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate. J. Rheumatol.. 1982; 9:224–228.
  • Vogt B., Führnrohr B., Müller R., Sheriff A.. CRP and the disposal of dying cells: Consequences for systemic lupus erythematosus and rheumatoid arthritis. Autoimmunity. 2007; 40:295–298.
  • McInnes I. B., Schett G.. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med.. 2011; 365:2205–2219.
  • Berdowska A., Zwirska-Korczala K.. Neopterin measurement in clinical diagnosis. J. Clin. Pharm. Therap.. 2001; 26:319–329.
  • Razumovitch J. A., Semenkova G. N., Fuchs D., Cherenkevich S. N.. Influence of neopterin on the generation of reactive oxygen species in human neutrophils. FEBS Lett.. 2003; 549:83–86.
  • Wirleitner B., Schroecksnadel K., Winkler C., Fuchs D.. Neopterin in HIV-1 infection. Mol. Immunol.. 2005; 42:183–194.
  • McInnes I. B., Schett G.. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol.. 2007; 7:429–442.
  • Choy E. H., Panayi G. S.. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med.. 2001; 33:222–230.
  • Renaudineau Y., Jamin C., Saraux A., Youinou P.. Rheumatoid factor on a daily basis. Autoimmunity. 2005; 38:11–16.
  • Vincent C., Nogueira L., Clavel C., Sebbag M., Serre G.. Autoantibodies to citrullinated proteins: ACPA. Autoimmunity. 2005; 38:17–24.
  • Syversen S. W., Gaarder P. I., Goll G. L., . High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann. Rheum. Dis.. 2008; 67:212–217.
  • Maddali Bongi S., Manetti R., Melchiorre D., . Anti-cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti-CCP and bone damage in RA. Autoimmunity. 2004; 37:495–501.
  • Agrawal S., Misra R., Aggarwal A.. Autoantibodies in rheumatoid arthritis: Association with severity of disease in established RA. Clin. Rheumatol.. 2007; 26:201–204.
  • Kurz K., Herold M., Winkler C., . Effects of adalimumab therapy on disease activity and interferon-γ-mediated biochemical pathways in patients with rheumatoid arthritis. Autoimmunity. 2011; 44:235–242.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.